ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,282.40
0.25%
Dow Jones
38,239.66
0.40%
Brent Oil
87.915
0.27%
Bitcoin
62,567.08
-0.69%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. National Research Corporation (NRC) Quote

National Research Corporation

National Research Corporation (NRC)

NASDAQ
33.81
0.22
(0.65%)
Closed April 26 4:00PM
Delayed by 15 minutes
33.81
0.00
( 0.00% )
Pre Market: 4:05AM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
33.81
Bid
30.56
Ask
37.16
Volume
-
0.00 Day's Range 0.00
32.08 52 Week Range 47.25
Market Cap
806.518M
Previous Close
33.81
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
61,537
Shares Outstanding
23,854,428
Dividend Yield
1.42%
PE Ratio
26.04
Earnings Per Share (EPS)
1.3
Revenue
148.58M
Net Profit
30.97M

About National Research Corporation

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solut... National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. The solutions are offered at an enterprise level through the Voice of the Customer platform, The Governance Institute, and legacy Experience solutions. Show more

Sector
Coml Physical, Biologcl Resh
Industry
Testing Laboratories
Website
www.nrchealth.com
Headquarters
Milwaukee, Wisconsin, USA
Founded
2004
National Research Corporation is listed in the Coml Physical, Biologcl Resh sector of the NASDAQ with ticker NRC. The last closing price for National Research was $33.81. Over the last year, National Research shares have traded in a share price range of $ 32.08 to $ 47.25.

National Research currently has 23,854,428 shares outstanding. The market capitalization of National Research is $806.52 million. National Research has a price to earnings ratio (PE ratio) of 26.04.

NRC Latest News

More News

National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet

National Research Corporation (NASDAQ:NRC) today announced that it will provide an online web simulcast of its 2024 first quarter earnings conference call on Wednesday, May 8, 2024. The Company’s...

April 18 2024
Business Wire

Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer

Baron will align and advance NRC Health’s experience solutions platform to solve health care industry challenges and continue effectively innovating and supporting experience improvement for...

April 02 2024
Business Wire

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

March 08 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

March 05 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

March 05 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

February 27 2024
Edgar (US Regulatory)

Form 8-K - Current report

February 13 2024
Edgar (US Regulatory)

National Research Corporation Announces Fourth Quarter and Calendar Year 2023 Results

National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2023. CEO Commentary Michael Hays, Chief Executive Officer, commented: “We’re pleased to...

February 13 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.06-0.17714791851233.8734.64533.36174796633.96571477CS
4-6.16-15.41155866939.9740.0132.084755435.11316525CS
12-3.02-8.1998370893336.834232.086153738.38481477CS
26-8.52-20.127569099942.3343.9832.086987739.68574846CS
52-9.6-22.114720110643.4147.2532.085124541.05238633CS
156-15.83-31.889605157149.6455.6730.934329441.27130924CS
260-5.55-14.100609756139.3671.352530.934064046.27174204CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSPICSP Inc
$ 18.46
(36.44%)
13
INHDInno Holdings Inc
$ 0.85
(34.81%)
3.02M
BBLGBone Biologics Corporation
$ 1.94
(26.80%)
76
AKANAkanda Corporation
$ 0.1279
(24.17%)
6.97M
CKPTCheckpoint Therapeutics Inc
$ 1.75
(22.38%)
47
CLVRClever Leaves Holdings Inc
$ 1.77
(-56.93%)
54.34k
ADXNAddex Therapeutics Ltd
$ 8.00
(-50.31%)
4.26k
ISUNiSun Inc
$ 0.1362
(-18.93%)
102.29k
NUZENuZee Inc
$ 1.37
(-15.95%)
5.38k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 33.27
(-15.28%)
157k
AKANAkanda Corporation
$ 0.1272
(23.50%)
6.97M
PEGYPineapple Energy Inc
$ 0.072
(15.02%)
4.02M
INHDInno Holdings Inc
$ 0.85
(34.81%)
3.02M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 8.22
(14.97%)
2.44M
TSLATesla Inc
$ 180.73
(7.39%)
2.06M

Discussion

View Full Feed
op1 op1 3 minutes ago
Hopeful for news this week
Evaluate buying if what’s expected
Strategy of averaging up on a positive development
WDDD
sctts sctts 3 minutes ago
$$$$ Today is the Day $$$$

$$$$ $frx $$$$
FRX
Sirpeter Sirpeter 5 minutes ago
Holding big bags...
CDXC
gdog gdog 9 minutes ago
nlst
NLST
misterfishman misterfishman 9 minutes ago
I'll take that......as a start lol.
IGPK
richthedude richthedude 10 minutes ago
Yup… you’re simply grasping at anything. Easy fix… don’t invest in SPZI, and go away- you’re really boring…. I’m up over 2500% since this run began, so you’re obviously not much of an investor, if you missed it. Sorry it didn’t work out for you pal.
SPZI
Chiron Chiron 11 minutes ago
Target .25
IGPK
kgromax kgromax 12 minutes ago
More evidence that Lemonlibag doesn’t prevent dementia
CYDY
JimmyTwoTimes JimmyTwoTimes 14 minutes ago
2 million added to OS
OWPC
Carthnel Carthnel 15 minutes ago
Great, looking forward to a triple deal discount with a Cannabix breathalyzer!
BLOZF
jay_tee jay_tee 20 minutes ago
Yep the .0002’s on deck are plentiful to put it lightly… We are struggling with .0001’s. I think everyone can agree, as long as the share structure is bloated we are screwed regardless of fins. This golden opportunity should at least have a bid. Seamus could easily put the cellar boxed theory to res
RNVA
Nutty investor Nutty investor 23 minutes ago
This is our update week I can feel it!
EMGE
rolvram rolvram 25 minutes ago
Meet the fund manager: Stephen Yiu on Meta, Nvidia and cashing in on the AI boom
BY:ELLIOT GULLIVER-NEEDHAM

Stephen Yiu, manager of Blue Whale Growth fund.
In this weekly series, investment reporter Elliot Gulliver-Needham sits down with a fund manager for a Q&A. This we
NVDA
newmedman newmedman 28 minutes ago
last one for here, I'll be exploring the whole album on my own... Have a good day folks. Hope I didn't wear out the carpet with all my pacing around.

[yt]tzVJPgCn-Z8[/yt]
leverage102 leverage102 29 minutes ago
NSAV,, a Sub Penny which is GENERATING 24.5 MILLION DOLLARS! Which is insane in itself. Aside from the Larger components ; we are a CRYPTOCURRENCY Company. With MASSIVE REVS which NO ONE EXPECTED 24.5 MILLION $$$. A New AIRDROP a Revolutionary platform, as well as the NSAV trading desk; with A.I
NSAV
Pnypnchr Pnypnchr 32 minutes ago
Sure glad I'm NOT one of those MFers, so inhumane towards people. SMFH
Edward Edward 33 minutes ago
This is what most like to call, “A Vote of Confidence” by the CEO.

???? LMAO The CEO is a known lowlife, a fake and a liar:

This is who shareholders of VXIT CEO James Katzaroff are dealing with:

http://www.clippercorporatepartners.com/2019/02/vivos-sla
VXIT
Tom turtles Tom turtles 35 minutes ago
Yes ..and the 1 time it was 100 shares that someone bought at .0002. I know cause I lost my bet with pumpkin farmer. Over a billion at .0002. It's going to be very hard sledding, even when and if the ones dry up.
RNVA
Gamco Gamco 38 minutes ago
InterDigital’s Doug Castor Elected Co-Chair of the ATIS Next G Alliance Steering Group

Source: GlobeNewswire Inc.

InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, announced the election of Doug Castor, InterDigital’s
IDCC
Methinks Methinks 39 minutes ago
https://economictimes.indiatimes.com/jobs/fresher/contemplating-a-career-in-cybersecurity-check-out-the-in-demand-skills-roles-and-pay/articleshow/109685199.cms
Take the stress out of cybersecurity - use Wave.
capgain capgain 40 minutes ago
Fav.
capgain capgain 40 minutes ago
Wow. Laurens, SC. Been through there a couple of times. Good song.
Methinks Methinks 42 minutes ago
https://processandcontrolmag.co.uk/solutionspt-sets-the-standard-for-cyber-secure-ot-systems-with-annual-cyber-secureot-conference/
Make it easier - use Wave.
BOOOOOM BOOOOOM 43 minutes ago
Please tell us more
IFUS
Methinks Methinks 44 minutes ago
https://www.electronicspecifier.com/products/cyber-security/new-cyber-laws-to-protect-consumers-from-cyber-criminals-come-into-force-in-the-uk
Wave could do away with all these new laws.

Your Recent History

NASDAQ
NRC
National Research
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved